Cite
Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation.
MLA
Samaras, Panagiotis, et al. “Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation.” Oncology, vol. 79, no. 1/2, Dec. 2010, pp. 93–97. EBSCOhost, https://doi.org/10.1159/000320604.
APA
Samaras, P., Buset, E. M., Siciliano, R. D., Haile, S. R., Petrausch, U., Mischo, A., Honegger, H., Pestalozzi, B. C., Schanz, U., Stussi, G., Stahel, R. A., Knuth, A., Renner, C., & Stenner-Liewen, F. (2010). Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation. Oncology, 79(1/2), 93–97. https://doi.org/10.1159/000320604
Chicago
Samaras, Panagiotis, Elefteri M. Buset, Raffaele Daniele Siciliano, Sarah R. Haile, Ulf Petrausch, Axel Mischo, Hanspeter Honegger, et al. 2010. “Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation.” Oncology 79 (1/2): 93–97. doi:10.1159/000320604.